This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. This document includes guidance on an important additional option for cervical screening, the use of mRNA (messenger RNA) HPV testing. This gives countries a...
To provide guidelines from the French College of Obstetricians and Gynecologists (CNGOF), based on the best evidence available, concerning subtotal or total hysterectomy, for benign disease. The CNGOF has decided to adopt the AGREE II and GRADE systems for grading scientific evidence. Each recommendation...
The objectives of these guidelines are to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and to support countries to update their national guidelines for the use of thermal ablation for cervical precancer....
The objectives of these guidelines are:
• to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and
• to support countries to update their national guidelines for the use of thermal ablation for cervical precancer.
These guidelines were developed using the W...
Esta guia tiene como objetivos dismunir la incidencia de lesiones cervicales intraepiteliales y del cancer de cuello uterino a traves de estrategias preventivas en salud; Establecer los criterios de referencia para ala tencion de la mujer en servicios especializados; Disminuir la mortalidad por cancer de...
Orozco, L;
Tristán, M;
Beitia, A;
Vreugdenhil, M. T;
Andrino, R;
Agüero, C;
García, M. E;
Umaña, A;
Guerrero, S;
Cruz, J;
Guidos, M;
Cárcamo, W;
Rodríguez, H.
Incluye recomendaciones sobre la prevención y manejo de lesiones premalignas y reducir la incidencia y mortalidad por cáncer cervicouterino....
Contribuir a mejorar la calidad de vida de las personas mediante la prevención y el manejo
adecuado del cáncer de cuello uterino (CCU). Establecer pautas para la prevención, detección temprana y manejo adecuado en casos de cáncer de cuello uterino a fin de reducir la morbilidad, mortalidad y discapa...
Al-Mandeel, H. M;
Sagr, E;
Sait, K;
Latifah, H. M;
Al-Obaid, A;
Al-Badawi, I. A;
Alkushi, A. O;
Salem, H;
Massoudi, N. S;
Schunemann, H;
Mustafa, R. A;
Brignardello-Petersen, R.
BACKGROUND: Cervical cancer is the third most common gynecological malignancy in Saudi women with an estimated incidence rate of 1.9 cases per 100 000 women-years. More than 40% of cervical cancer cases are diagnosed at advanced stages due to lack of a routine screening program in Saudi Arabia. Thus, nat...
Sankaranarayanan, R;
Tsu, V;
Broutet, N;
Santesso, N;
Mustafa, RA;
Schünemann, HJ;
Arbyn, M;
Blumenthal, PD;
Cain, J;
Chirenje, M;
Denny, L;
De, Vuyst, H;
Eckert, LO;
Forhan, SE;
Franco, EL;
Gage, JC;
Garcia, F;
Herrero, R;
Jeronimo, J;
Lu, ER;
Luciani, S;
Quek, SC.
"BACKGROUND:
It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%. If left untreated, CIN 2-3 can progress to cervical cancer. WHO has previously published guidelines for strateg...
This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and c...
